Experts review current treatments for metastatic castration-sensitive prostate cancer, centering their discussion around a patient case.
ONCOLOGY® Companion, Volume 37, Supplement 7
Key points from a discussion of the role of bispecific antibodies in the treatment of multiple myeloma.
Key points from a discussion of the clinical data behind both BCMA- and non–BCMA-targeting bispecifics in multiple myeloma.
Experts review treatment options for acute graft-versus-host disease and discuss data from post hoc analyses of the REACH2 trial.
Advertisement
Advertisement
Trending on CancerNetwork
1
Sac-TMT Combo Produces Encouraging Activity in Pretreated Metastatic CRPC
2
Zurletrectinib Generates Responses in Advanced NTRK Fusion Solid Tumors
3
FDA Grants Interchangeability Designation to 2 Denosumab Biosimilars
4
Molecular Insights Into Cancer Cachexia: An Evolution in Identifying the Syndrome
5
